Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
Rchr
J-GLOBAL ID：201801005938211965
Update date: Jul. 19, 2024 Wada Hiromichi
ワダ ヒロミチ | Wada Hiromichi
- 2013 - 2018 Establishment of the method to extract a high-risk population employing novel biomarkers to predict cardiovascular events in Japan
- 2012 - 2015 The relationships of vascular endothelial growth factor-C with atherosclerosis and cardiovascular events
- 2009 - 2011 The role of soluble VEGF receptor in cardiovascular risk of metabolic syndrome and smoking
- 2006 - 2007 メタボリック症候群の心筋血管新生における可溶性血管内皮増殖因子受容体2の役割
- Swati Mittal, Maki Komiyama, Yuka Ozaki, Hajime Yamakage, Noriko Satoh-Asahara, Hiromichi Wada, Akihiro Yasoda, Masafumi Funamoto, Yasufumi Katanasaka, Yoichi Sunagawa, et al. Impact of smoking initiation age on nicotine dependency and cardiovascular risk factors: a retrospective cohort study in Japan. European heart journal open. 2024. 4. 1. oead135
- Syuhei Ikeda, Yoshimori An, Moritake Iguchi, Hisashi Ogawa, Yumiko Nakanishi, Kimihito Minami, Kenjiro Ishigami, Yuya Aono, Kosuke Doi, Yasuhiro Hamatani, et al. Proteinuria is independently associated with heart failure events in patients with atrial fibrillation: The Fushimi AF registry. European heart journal. Quality of care & clinical outcomes. 2023
- Maki Komiyama, Yuka Ozaki, Hiromichi Wada, Hajime Yamakage, Noriko Satoh-Asahara, Akihiro Yasoda, Yoichi Sunagawa, Tatsuya Morimoto, Shinji Tamaki, Masahiro Suzuki, et al. Randomized double-blind placebo-controlled multicenter trial for the effects of a polyherbal remedy, Yokukansan (YiganSan), in smokers with depressive tendencies. BMC Complementary Medicine and Therapies. 2022. 22. 1
- Yasuhiro Hamatani, Hidehisa Nishi, Moritake Iguchi, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Shunichi Fukuda, et al. Machine Learning Risk Prediction for Incident Heart Failure in Patients With Atrial Fibrillation. JACC. Asia. 2022. 2. 6. 706-716
- Yasufumi Katanasaka, Yoichi Sunagawa, Yusuke Miyazaki, Masafumi Funamoto, Satoshi Shimizu, Kana Shimizu, Hajime Yamakage, Noriko Satoh-Asahara, Kazushige Toyama, Toru Sabashi, et al. Ameliorating prediabetic subject status via fermented tea supplementation: A randomized, double-blind, parallel-group comparison study. Journal of Functional Foods. 2022. 97. 105257-105257
- 渡邉 真広, 網代 洋一, 森 文章, 岩出 和徳, 古谷 良輔, 小松 達司, 長谷川 浩二, 和田 啓道, 石井 充, 橋本 大哉, et al. Risk Score of Successful Weaning from Veno-Arterial Extracorporeal Membrane Oxygenation: National Hospital Organization Multicenter Cohort Study(和訳中). 日本循環器学会学術集会抄録集. 2022. 86回. JO03-8
- 山田美帆, 片桐宇大, 前川健也, 清水聡史, 清水聡史, 砂川陽一, 砂川陽一, 砂川陽一, 刀坂泰史, 刀坂泰史, et al. ヒスチジン含有ジペプチドのAnserineは圧負荷誘導性心不全モデルマウスの心収縮能の低下を抑制した. 日本薬理学雑誌. 2022. 157. Supplement
- 高井秀通, 砂川陽一, 砂川陽一, 砂川陽一, 船本雅文, 船本雅文, 清水果奈, 清水果奈, 清水聡史, 清水聡史, et al. 新規クルクミン製剤であるcurcuRougeは心筋梗塞モデルラットにおいて心収縮能の低下を抑制した. 日本薬理学雑誌. 2022. 157. Supplement
- 清水聡史, 清水聡史, 砂川陽一, 砂川陽一, 砂川陽一, 刀坂泰史, 刀坂泰史, 刀坂泰史, 宮崎雄輔, 宮崎雄輔, et al. GATA-binding protein 4は二量体を形成することで心筋細胞肥大反応の転写活性化をする. 日本薬理学雑誌. 2021. 156. Supplement
- 片桐宇大, 山田美帆, 前川健也, 清水聡史, 清水聡史, 砂川陽一, 砂川陽一, 砂川陽一, 刀坂泰史, 刀坂泰史, et al. イミダゾールジペプチドであるAnserineは心筋細胞肥大反応抑制作用を示した. 日本薬理学雑誌. 2021. 156. Supplement
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.
Return to Previous Page
